Cite
HARVARD Citation
Zhai, J. et al. (2022). First‐line PD‐1/PD‐L1 inhibitors plus chemotherapy versus bevacizumab plus chemotherapy for advanced non‐squamous non‐small cell lung cancer: A Bayesian network meta‐analysis of randomized controlled trials. Cancer medicine. pp. 2043-2055. [Online].